Sotalol Hydrochloride Tablet
Product Images NDC 59651-775

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 59651-775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sotalol Fig1)

Figure 1 (Sotalol Fig1)
A pharmacokinetic curve chart displaying the relationship between age in months (x-axis) and age factor (y-axis). The graph shows a curve increasing from 0.1 to 50 months with the age factor rising from approximately 0.15 to 1.0, leveling off as age approaches 24 months and beyond.*
FDA Label Image

Figure 1: Study 1 (Sotalol Fig2)

Figure 1: Study 1 (Sotalol Fig2)
A Kaplan-Meier survival curve chart depicting recurrence-free survival over time (days) for oral Sotalol versus placebo. The graph compares three Sotalol dosages: 80 mg, 120 mg, and 160 mg, with corresponding survival probabilities over 360 days. A table shows log-rank P-values comparing each dosage to placebo.*
FDA Label Image

Figure 2: Study 2 (Sotalol Fig3)

Figure 2: Study 2 (Sotalol Fig3)
A Kaplan-Meier survival curve showing recurrence-free survival over 180 days comparing oral sotalol hydrochloride versus placebo. The vertical axis represents recurrence-free survival probability, and the horizontal axis shows time in days. The figure includes a p-value of 0.002 from a log-rank test comparing the two groups.*
FDA Label Image

Package Label-principal Display Panel (80 mg (100 Tablets Bottle))

Package Label-principal Display Panel (80 mg (100 Tablets Bottle))
Label for Sotalol HCl Tablets USP (AF) 80 mg tablet, oral dosage form. The package contains 100 tablets and is distributed by Aurobindo Pharma USA, Inc., made in India. The label includes storage instructions, dosage, and a depiction of a round tablet imprinted with "S 80." National Drug Code (NDC) 59651-775-01 is visible along with a barcode.*
FDA Label Image

Package Label-principal Display Panel (120 mg (100 Tablets Bottle))

Package Label-principal Display Panel (120 mg (100 Tablets Bottle))
Label for Sotalol Hydrochloride Tablets USP 120 mg, oral tablets from Aurobindo Pharma Limited. The label indicates 100 tablets per container and states storage and handling instructions, including that each tablet contains 120 mg of sotalol hydrochloride. It includes distribution information for Aurobindo Pharma USA, Inc. and a barcode on the right side.*
FDA Label Image

Package Label-principal Display Panel (160 mg (100 Tablets Bottle))

Package Label-principal Display Panel (160 mg (100 Tablets Bottle))
Label for Sotalol HCl Tablets USP (AF) 160 mg oral tablets by Aurobindo Pharma Limited. The package contains 100 tablets. The label includes storage instructions, dosage advice to refer to prescribing information, and distributor details for Aurobindo Pharma USA, Inc. A tablet image marked 'S 160' is also shown.*
FDA Label Image

Chemical Structure (Sotalol Str)

Chemical Structure (Sotalol Str)
Chemical structure of Sotalol Hydrochloride showing a benzene ring substituted with a methanesulfonamide group and a side chain containing an alcohol, amine, and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.